Back to Search
Start Over
GW29-e1702 Bepridil a class IV antiarrhythmic agent can block TREK-1 potassium channel
- Source :
- Journal of the American College of Cardiology. 72:C55
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
-
Abstract
- The two-pore domain potassium (K2P) channel TREK-1 is recognized as a new and major candidate of cardiac stretch-activated potassium current and play a key role in the pathogenesis of human cardiac arrhythmias and heart failure. However, there is little study about the effect of antiarrhythmic drugs
Details
- ISSN :
- 07351097
- Volume :
- 72
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........2a85d1f7c1d92ede74e718e6845fb6a9
- Full Text :
- https://doi.org/10.1016/j.jacc.2018.08.201